PepLabo Download

Victoza® and burping

Burping more than usual, sometimes with a sour or eggy taste, is one of the less discussed effects people notice after starting a GLP-1 medicine. With Victoza®, the daily liraglutide injection for type 2 diabetes, the three main sets of product information disagree on whether burping belongs on the list at all. This page explains where it appears, which nearby reactions are better measured, why a slower stomach may play a part, and which signs mean the burping is not the real problem.

Published · Updated · Victoza®: side effects by symptom · Written by the PepLabo editorial team

Listed in Canada, not in the US or EU

Health Canada’s Patient Medication Information for Victoza® includes burping in its list of common side effects, alongside indigestion, gastritis, reflux disease, a painful or swollen tummy and wind. [3] Yet the monograph’s own trial tables, which print every event above 1% in each study, have no row for burping or eructation, its medical name. [3] The likeliest reading is that burping happened in fewer than 1% in any single trial but was still judged part of the drug’s profile.

The US prescribing information does not mention burping. [1] The European summary of product characteristics does not list eructation either, although it places several neighbouring upper-stomach reactions in the common band. [2] So for Victoza® specifically, burping is acknowledged but not measured.

Burping and related upper-stomach reactions in Victoza® product information (checked 20-10-2026)
SourceBurpingRelated reactions
US label, Table 1 [1]Not listedDyspepsia: placebo 1%; 1.2 mg 4%; 1.8 mg 7%
EU SmPC, Table 1 [2]Not listedDyspepsia, gastritis, reflux disease, flatulence: common
Canada, Patient Medication Information [3]Common (fewer than 1 in 10)Indigestion, gastritis, reflux disease: common
Canada, LEAD-2: dyspepsia [3]No row0.6 mg 3.7%; 1.2 mg 2.1%; 1.8 mg 7.0%; placebo 0.8%; glimepiride 1.2%
Canada, trial 1860: reflux disease [3]No row1.2 mg 1.4%; 1.8 mg 2.3%; sitagliptin 0.9%
Saxenda® 3 mg, Table 2 (higher dose) [4]4.5% vs 0.2% placeboReflux disease 4.7% vs 1.7%

Why a GLP-1 medicine might cause more burping

Label-supported: the US label states that Victoza® delays gastric emptying. [1] A stomach that holds its contents longer can build up more gas and pressure, and belching is one way that pressure is released. Europe lists dyspepsia and reflux disease as common, both of which often come with belching. [2]

Measured, but not in Victoza® users: in a 5-week study of adults with obesity and no diabetes, liraglutide 1.8 mg slowed emptying over the first hour by 13% against placebo, a difference that did not reach significance, while 3 mg slowed it by 23%. [6] This may help explain why the higher Saxenda® dose shows burping in its table and the lower Victoza® doses do not. [4][6]

Population studies point the same way for reflux. A large US health-record study found that starting shorter-acting GLP-1 medicines, a group that included liraglutide, was linked with more erosive reflux disease than other second-line diabetes medicines, and the link held for liraglutide on its own. [5] A UK cohort found reflux disease 27% more likely on GLP-1 medicines as a class than on SGLT-2 inhibitors. [7] These are observational studies; they show an association, not proof that the drug caused it.

About “sulfur burps”

Many people describe GLP-1 burps as smelling of rotten eggs. None of the Victoza® documents, US, EU or Canadian, mentions sulfur or egg-smelling burps. [1][2][3] NIDDK mentions sulfur only as a cause of unpleasant odour in gas passed from the bowel; it does not discuss burps. [8] If the taste is sour rather than eggy, reflux is the more likely explanation, and the separate page on Victoza® and heartburn covers that in detail.

Other causes of frequent burping

Cleveland Clinic names swallowed air as the most common cause of excessive belching: eating or drinking quickly, talking while eating, chewing gum, sucking hard sweets, fizzy drinks, smoking, poorly fitting dentures and breathing through the mouth. [9] Beans, lentils, cabbage, onions, broccoli and cauliflower can add to it. [9]

It also lists medical conditions in which belching is a symptom: reflux disease, functional dyspepsia, gastroparesis, gastritis, peptic ulcers, lactose intolerance, H. pylori infection and small intestinal bacterial overgrowth. [9] Gastroparesis matters in type 2 diabetes, and the US label says Victoza® is not recommended for people with severe gastroparesis. [1][8]

What the sources describe

  • Sit down to eat and take your time; eating quickly and talking while eating add swallowed air. [9]
  • Skip chewing gum, hard sweets, straws and fizzy drinks, including beer. [8][9]
  • Lying on your side or in a knee-to-chest position until the gas passes is a home step Cleveland Clinic describes. [9]
  • If burping comes with heartburn, MedlinePlus advises avoiding food within 3 to 4 hours of bedtime and not bending over or exercising just after meals. [10]
  • Ask your pharmacist before over-the-counter remedies, and do not stop or change a medicine on your own because you suspect it, as MedlinePlus advises. [10]

Victoza® and Saxenda® are registered trademarks of Novo Nordisk A/S. PepLabo is not affiliated with or endorsed by Novo Nordisk A/S.

When to get help

SignWho to contactHow fastSource
Burping or burning with squeezing, crushing or pressing chest pain, sweating or breathlessnessEmergency services (911 or local number)EmergencyMedlinePlus [10]; Cleveland Clinic [9]
Vomit that is bloody or looks like coffee grounds, or black, tarry stoolsUrgent medical careEmergencyMedlinePlus [10]
Severe stomach pain that will not go away, with or without vomitingStop Victoza® and call your provider right awayEmergencyMedication Guide [1]
Burping with fever, abdominal pain, unexplained weight loss, vomiting or diarrhoeaContact your providerTodayCleveland Clinic [9]
Trouble swallowing, food feeling stuck, or a cough that will not go awayContact your providerTodayMedlinePlus [10]
Burping that does not settle after the first weeks or bothers daily lifeRaise it with your prescriberAt your next appointmentMedication Guide [1]; NIDDK [8]

Questions

Is burping a known side effect of Victoza®?

Canada’s patient leaflet lists it as common. [3] The US and EU documents do not list burping, though they record indigestion and reflux. [1][2]

Why do my burps on Victoza® smell like eggs?

No Victoza® document mentions sulfur burps. [1][2][3] NIDDK links sulfur to the odour of gas from the bowel, not to burps. [8] Note what you ate beforehand and mention it to your prescriber.

Will the burping stop after the first weeks?

Europe says digestive reactions on Victoza® are more frequent at the start and usually ease within days or weeks. [2] There is no Victoza®-specific timeline for burping itself.

I switched from Saxenda® to Victoza®. Should burping improve?

Saxenda® reports burping in 4.5% of people at up to 3 mg, while Victoza® tops out at 1.8 mg and its tables show no burping row. [3][4] Lower doses may matter, but no study compares the two directly.

Is burping on Victoza® a sign of something serious?

Usually not, according to Cleveland Clinic. [9] Burping with chest pressure, bloody or coffee-ground vomit, black stools or severe pain needs urgent care. [10]

Can I take an antacid for burping on Victoza®?

The US label asks for caution with oral medicines because Victoza® slows stomach emptying, although tested medicines were not affected to a relevant degree. [1] Ask your pharmacist which remedy fits you.

Sources

Sources checked on

  1. VICTOZA® (liraglutide) injection Prescribing Information and Medication Guide, Novo Nordisk Revised 10/2025; Medication Guide 05/2025. Sections 5.6, 5.9, 6.1 (Table 1), 7.1 and Medication Guide.
  2. Victoza: EPAR – Product Information (SmPC and package leaflet), European Medicines Agency SmPC section 4.8 (Table 1 read from the PDF page image); package leaflet section 4.
  3. VICTOZA® (liraglutide injection) Product Monograph, Novo Nordisk Canada Inc. (Health Canada Drug Product Database) Date of authorization 2025-08-21. Section 8.2 (Tables 1–2 read from the PDF page images) and Patient Medication Information.
  4. SAXENDA® (liraglutide) injection Prescribing Information, Novo Nordisk Revised 02/2026. Section 6.1, Table 2.
  5. Liu BD et al. Shorter-acting glucagon-like peptide-1 receptor agonists are associated with increased development of gastro-oesophageal reflux disease and its complications in patients with type 2 diabetes mellitus. Gut 2024 Propensity-matched health-record cohort (TriNetX); PubMed abstract.
  6. van Can J et al. Effects of the once-daily GLP-1 analog liraglutide on gastric emptying, glycemic parameters, appetite and energy metabolism in obese, non-diabetic adults. Int J Obes 2014 Randomized incomplete crossover trial, 49 adults; PubMed abstract.
  7. Noh Y et al. Glucagon-like peptide-1 receptor agonists and risk for gastroesophageal reflux disease in patients with type 2 diabetes: a population-based cohort study. Ann Intern Med 2025 Active-comparator cohort, UK primary care data; PubMed abstract.
  8. Symptoms & Causes of Gas in the Digestive Tract, NIDDK (NIH) Last reviewed June 2021. Gastroparesis: https://www.niddk.nih.gov/health-information/digestive-diseases/gastroparesis/symptoms-causes
  9. Belching, Cleveland Clinic Last updated 10/31/2024.
  10. Heartburn, MedlinePlus Medical Encyclopedia (U.S. National Library of Medicine)

Set up your lab tonight.

It takes a few minutes. Pep will be waiting.